Login / Signup

Intralesional brentuximab vedotin for the treatment of primary cutaneous T-cell lymphomas: a case series.

Jorge Arroyo-AndresManuel Agud-DiosCarmen A Rubio-MunizConcepción PostigoSusana Cortijo-CascajaresPablo L Ortiz-Romero
Published in: International journal of dermatology (2023)
Keyphrases
  • hodgkin lymphoma
  • replacement therapy